Together, these data implicate AXL inhibition by miR-34 as a downstream mediator of p53-induced apoptosis and suggest an additional mechanism for AXL inhibitors in CLL (Figure 2). This evidence concerns the gene TP53 and B-cell chronic lymphocytic leukemia.